SPONSOR
Henan Cancer Hospital
Total Trials
2
Recruiting
2
Phases
Phase 2
Henan Cancer Hospital is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Metastatic Breast Cancer, Breast Cancer, HER2-positive Breast Cancer.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Henan Cancer Hospital
How many clinical trials has Henan Cancer Hospital sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Henan Cancer Hospital, of which 2 are actively recruiting participants. These trials cover conditions including Metastatic Breast Cancer, Breast Cancer, HER2-positive Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Henan Cancer Hospital research focus on?
Henan Cancer Hospital clinical trials span Metastatic Breast Cancer, Breast Cancer, HER2-positive Breast Cancer. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Henan Cancer Hospital clinical trial?
To participate in a Henan Cancer Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Henan Cancer Hospital trials with current recruitment status updated daily.
Clinical Trials by Henan Cancer Hospital
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology